Regarding SARS‐CoV‐2 vaccination, some evidence suggests that CD4+ T cell cytokine responses and neutralizing antibody titers are lower in people with T2D with higher glycemic exposure compared with those with glucose levels close to target and people without diabetes [7], while other investigations did not observe differences in antibody titers [8]. This evidence concerns the gene CD4 and diabetes mellitus.